- Previous Close
29,101.90 - Open
29,066.85 - Bid 29,797.05 x --
- Ask 29,840.00 x --
- Day's Range
29,066.85 - 29,840.00 - 52 Week Range
25,200.05 - 30,683.40 - Volume
1,575 - Avg. Volume
459 - Market Cap (intraday)
632.038B - Beta (5Y Monthly) 0.01
- PE Ratio (TTM)
47.31 - EPS (TTM)
628.70 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield 410.00 (1.57%)
- Ex-Dividend Date Jul 19, 2024
- 1y Target Est
29,838.57
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
www.abbott.co.in3,814
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ABBOTINDIA.BO
View MorePerformance Overview: ABBOTINDIA.BO
Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABBOTINDIA.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABBOTINDIA.BO
View MoreValuation Measures
Market Cap
633.15B
Enterprise Value
614.90B
Trailing P/E
47.45
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.14
Price/Book (mrq)
17.98
Enterprise Value/Revenue
9.85
Enterprise Value/EBITDA
32.77
Financial Highlights
Profitability and Income Statement
Profit Margin
21.18%
Return on Assets (ttm)
19.22%
Return on Equity (ttm)
38.75%
Revenue (ttm)
60.66B
Net Income Avi to Common (ttm)
12.85B
Diluted EPS (ttm)
628.70
Balance Sheet and Cash Flow
Total Cash (mrq)
11.06B
Total Debt/Equity (mrq)
1.72%
Levered Free Cash Flow (ttm)
1.11B